Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC
Shenlingcao Oral Liquid for Patients With Stage II or IIIA Non-small Cell Lung Cancer Receiving Radical Resection: A Pragmatic, Multicenter Randomized Controlled Trial
Sponsor: West China Hospital
A PHASE4 clinical study on Carcinoma, Non-Small-Cell Lung and Chemotherapy, Adjuvant, this trial is completed. The trial is conducted by West China Hospital and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jul 2022 — Jun 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Feb 2021 — Jul 2022 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Dec 2018 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- West China Hospital
For direct contact, visit the study record on ClinicalTrials.gov .